Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $938.08 | 44 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $127.35 | 5 | $0 (2024) |
| Lilly USA, LLC | $115.60 | 6 | $0 (2024) |
| Amgen Inc. | $110.37 | 5 | $0 (2024) |
| Astellas Pharma US Inc | $83.73 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $69.49 | 3 | $0 (2024) |
| ABBVIE INC. | $67.21 | 3 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $57.32 | 2 | $0 (2023) |
| Exact Sciences Corporation | $55.63 | 3 | $0 (2023) |
| Abbott Laboratories | $42.56 | 2 | $0 (2023) |
| Hikma Pharmaceuticals USA | $34.88 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $372.41 | 18 | ABBVIE INC. ($67.21) |
| 2023 | $565.67 | 26 | PFIZER INC. ($106.50) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: ANTIBIOTIC | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Gastroenterology | ||||||
| 11/05/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Obesity | ||||||
| 10/29/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $24.07 | General |
| Category: Bone Health | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: VACCINES | ||||||
| 08/20/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: VACCINES | ||||||
| 08/06/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Biological | ||||||
| 07/24/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: Bone Health | ||||||
| 06/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: NEUROLOGY | ||||||
| 04/24/2024 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Neurology | ||||||
| 04/16/2024 | Hikma Pharmaceuticals USA | Ryaltris (Drug), Kloxxado | Food and Beverage | In-kind items and services | $20.28 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | Hikma Pharmaceuticals USA | Kloxxado (Drug), Ryaltris, Mitigare | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 01/09/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Biological | ||||||
| 12/29/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Neuromodulation | ||||||
| 12/13/2023 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Bone Health | ||||||
| 11/09/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Diabetes | ||||||
| 10/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: Diabetes | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: VACCINES | ||||||
| 10/04/2023 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $23.46 | General |
| Category: Neurology | ||||||
| 09/14/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,380 | 1,858 | $407,098 | $197,942 |
| 2022 | 8 | 915 | 1,089 | $187,883 | $96,937 |
| 2021 | 9 | 872 | 1,004 | $165,856 | $89,288 |
| 2020 | 11 | 837 | 992 | $177,516 | $78,888 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 269 | 528 | $184,800 | $79,778 | 43.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 198 | 325 | $73,125 | $34,664 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 225 | 225 | $33,750 | $30,668 | 90.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 91 | 91 | $36,400 | $16,606 | 45.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 83 | 83 | $25,398 | $11,516 | 45.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 58 | $8,700 | $4,114 | 47.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $4,340 | $3,956 | 91.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $8,120 | $3,431 | 42.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 30 | 30 | $3,600 | $2,158 | 59.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 20 | $3,000 | $2,091 | 69.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 30 | 32 | $2,560 | $1,984 | 77.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 20 | 29 | $5,220 | $1,265 | 24.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,190 | $1,099 | 92.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 25 | 53 | $2,385 | $1,032 | 43.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 81 | 93 | $2,325 | $781.20 | 33.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 57 | 60 | $7,500 | $743.88 | 9.9% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 15 | 20 | $800.00 | $536.01 | 67.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 14 | 14 | $490.00 | $452.48 | 92.3% |
| 99422 | Online digital evaluation and management service for an established patient for up to 7 days, total time 11-20 minutes | Office | 2023 | 16 | 16 | $1,152 | $396.60 | 34.4% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2023 | 21 | 24 | $840.00 | $287.46 | 34.2% |
| 99421 | Online digital evaluation and management service for an established patient for up to 7 days, total time 5-10 minutes | Office | 2023 | 15 | 16 | $608.00 | $202.55 | 33.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 34 | 53 | $795.00 | $180.73 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 267 | 267 | $69,761 | $37,317 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 182 | 277 | $36,740 | $19,184 | 52.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 84 | 143 | $30,007 | $16,135 | 53.8% |
About Dr. Carole Prete, MD
Dr. Carole Prete, MD is a Internal Medicine healthcare provider based in Winnetka, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831258391.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Carole Prete, MD has received a total of $938.08 in payments from pharmaceutical and medical device companies, with $372.41 received in 2024. These payments were reported across 44 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($938.08).
As a Medicare-enrolled provider, Prete has provided services to 4,004 Medicare beneficiaries, totaling 4,943 services with total Medicare billing of $463,055. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Winnetka, IL
- Active Since 12/08/2006
- Last Updated 12/20/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1831258391
Products in Payments
- PREVNAR 20 (Biological) $110.86
- EVENITY (Biological) $110.37
- MOUNJARO (Drug) $83.42
- Veozah (Drug) $70.85
- SHINGRIX (Biological) $69.49
- Kerendia (Drug) $57.32
- Cologuard Collection Kit (Device) $55.63
- VRAYLAR (Drug) $47.61
- XIFAXAN (Drug) $30.08
- INSPIRE (Device) $26.30
- APLENZIN (Drug) $23.46
- Sunosi (Drug) $23.31
- PROCLAIM (Device) $23.09
- Ozempic (Drug) $21.79
- NUZYRA (Drug) $20.91
- Ryaltris (Drug) $20.28
- SYNTHROID (Drug) $19.60
- ETERNA (Device) $19.47
- JARDIANCE (Drug) $17.47
- PAXLOVID (Drug) $16.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Winnetka
Dr. Kristi Tough Desapri, M.d, M.D
Internal Medicine — Payments: $328,189
Dr. Alfred Torrence, Md, MD
Internal Medicine — Payments: $3,090
Claire Kenneally, M.d, M.D
Internal Medicine — Payments: $3,024
David Donnersberger, Md, MD
Internal Medicine — Payments: $2,336
Dr. Robin Wind, M.d, M.D
Internal Medicine — Payments: $2,236
Roman Mandzij, Do, DO
Internal Medicine — Payments: $1,991